李苗苗,安莲华,张红梅,左程,刘鑫,姜宏宇

• 1:吉林大学第一医院体检中心

摘要(Abstract)：

<正>传统上,普遍认为脂肪组织为能源仓库,由于肥胖和代谢疾病发病率的迅速增加,脂肪组织也获得了巨大的研究价值,其分泌的脂肪因子除了调节脂肪存储和养分平衡,还参与了胰岛素抵抗(IR)、糖脂代谢、炎症调节等病理生理过程。21世纪,糖尿病已成为一种世界范围内的流行病,而其大血管并发症,即动脉粥样硬化所致的心脑血管疾病,是造成患者死亡的主要原因。本文旨在对糖尿病动脉粥样硬化作用较突出的部分脂肪因子作一综述,以阐述其对该病理过程的影响。

关键词(KeyWords)： 脂肪因子;瘦素;脂联素;网膜素;糖尿病;动脉粥样硬化

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金课题(No.81272471);; 吉林省自然科学基金课题(No.201115066)

作者(Author): 李苗苗,安莲华,张红梅,左程,刘鑫,姜宏宇

参考文献(References)：

• 1 Udagawa J,Hatta T,Naora H,et al.Expression of the long form of the long form of leptin receptor(Ob-Rb)mRNA in the brain of mouse embryos and newborn mice〔J〕.Brain Res,2000;868(2):251-8.
• 2 Procaccini C,Jirillo E,Matarese G.Leptin as an immunomodulator〔J〕.Mol Aspects Med,2012;33(1):35.
• 3 Seufert J,Kieffer TJ,Leech CA,et al.Leptin suppression of insulin secretion and gene expression in human pancreatic islets:implications for the development of adipogenic diabetes mellitus〔J〕.J Clin Endocrinol Metab,1999;84(2):670-6.
• 4 张诺,郝餐.2型糖尿病和肥胖患者瘦紊与胰岛素敏感性的关系〔J〕.中国误诊学杂志,2008;8(13):3053-4.
• 5 Gupta A,Gupta V,Agrawal S,et al.Association between circulating leptin and insulin resistance,the lipid profile,and metabolic risk factors in North Indian adult women〔J〕.Biosci Trends,2010;4(6):325-32.
• 6 Singh M,Bedi US,Sinsh PP,et al.Leptin and the clinical cardiovascular risk〔J〕.Int J Cardiol,2010;140(3):266-71.
• 7 Rodriguez A,Fortuno A,Gomez-Ambrosi J.The inhibitory effect of leptin on angiotensinⅡ-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism〔J〕.Endocrinology,2007;148(1):324-31.
• 8 Scherer PE,Williams S,Fogliano M,et al.A novel serum protein similar to C1q,produced exclusively in adipocytes〔J〕.J Biol Chem,1995;270(45):26746-9.
• 9 Maeda K,Okubo K,Shimomura I,et al.cloning and expression of novel adipose specific collagen 2-like factor,ap MI(Adipose Most abundant Gene transcript 1)〔J〕.Boichem Biophys Res Commun,1996;221(2):286.
• 10 Arita Y,Kihara H,Ouchi N,et al.Paradoxical decrease of an adipose specific protein,adiponectin,in obesity〔J〕.Biochem Biophiys Res Commu,1999;257(1):79-83.
• 11 Berg AH,Combs TP,Du X,et al.The adipocyte-secreted protein Acrp30enhances hepatic insulin action〔J〕.Nat Med,2001;7(8):947-53.
• 12 Weyer C,Funahashi T,Tanaka S,et al.Hypoadiponectinemia in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia〔J〕.J Clin Endocrinol Metab,2001;86(5):1930-5.
• 13 Kishida K,Funahashi T,Shimomura I.Molecular mechanisms of diabetes and atherosclerosis:role of adiponectin〔J〕.Endocr Metab Immune Disord Drug Targets,2012;12(2):118-31.
• 14 Jang C,Inder WJ,Obeyesekere VR,et al.Adiponectin,skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone〔J〕.Clin Endocrinol(Qxf),2008;69(5):745-50.
• 15 Boonard C,Durand A,Vidal H,et al.Changes in adiponectin,its receptors and AMPK activity in tissues of diet-induced diabetic mice〔J〕.Diabetes Metab,2008;34(1):52-61.
• 16 Ouedraogo R,Gong Y,Berzins B,et al.Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo〔J〕.J Clin Invest,2007:117(6):1718-26.
• 17 Zhang H,Zhang J,Ungvari Z,et al.Resveratrol improves endothelial function:role of TNF{alpha}and vascular oxidative stress〔J〕.Arterioscler Thromb Vasc Biol,2009;29:1164-71.
• 18 Motobayashi Y,Izawa-Ishizawa K,Ishizaua K,et al.Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation,but not Akt in vascular smooth muscle cells〔J〕.Hyperten Res,2009;32(3):188-93.
• 19 Ouchi N,Kihara S,Arita Y,et al.Adipocyte-derived plasma protein,adiponectin,suppresses,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages〔J〕.Circulation,2001;103(8):1057-63.
• 20 Tsatsanis C,Zacharioudaki V,Androulidaki A,et al.Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli〔J〕.Biochem Biophys Res Commun,2005;335(4):1254-63.
• 21 Yang RZ,Lee MJ,Hu H,et al.Identification of omentin as a novel depot-specific adipokine in human adipose tissue:possible role in modulating insulin action〔J〕,Am J Physiol Endocrinol Metab,2006;290(6):E1253-61.
• 22 Yan P,Liu D,Long M,et al.Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus〔J〕.Exp Clin Endocrinol Diabetes,2011;119(4):257-63.
• 23 Vionnet N,Hani EH,Dupont S,et al.Genomewide search for type 2 diabetes-susceptibility genes in French whites:evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2diabetes locus on chromosome 1q21-q24〔J〕.Am J Hum Genet,2000;67(6):1470-80.
• 24 Duan XY,Xie PL,Ma YL,et al.Omentin inhibits osteoblastic dif-ferentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway〔J〕.Amino Acids,2011;41(5):1223-31.
• 25 Maruyama S,Shibata R,Kikuchi R,et al.Fat-derived factor Omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide syn-thase-dependent mechanism〔J〕.J Biol Chem,2012;287(1):408-17.
• 26 Yamawaki H,Tsubaki N,Mukohda M,et al.Omentin,a novel adipokine,induces vasodilation in rat isolated blood vessels〔J〕.Biochem Biophys Res Commun,2010;393(4):668-72.
• 27 Kazama K,Usui T,Okada M,et al.Omentin plays an antiinflamma-tory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells〔J〕.Eur J Pharmacol,2012;686(1-3):116-23.